Gaelic Laboratories, a world-class manufacturer of Beta-Lactam (penicillin) products, today announces its acquisition of Athlone Laboratories, a leading developer and manufacturer of oral dose Beta-Lactams, in a step that strengthens Gaelic’s market position, enhances manufacturing capabilities, and leverages supply chain efficiencies. .

盖尔实验室，世界一流的β-内酰胺（青霉素）产品制造商，今天宣布收购领先的口服剂量β-内酰胺开发商和制造商阿斯隆实验室，此举加强了盖尔的市场地位，提升了制造能力，并利用了供应链效率。

Thanks to its business-friendly climate and stable political environment, which actively supports the pharmaceutical industry, Ireland is now a global hub for pharmaceutical manufacturing. This merger of the country’s two leading producers of Beta-Lactam products presents significant opportunities for future growth and enhanced efficiencies, yielding significant benefits for both companies, their stakeholders, partners and customers. .

由于其商业友好的环境和积极支持制药行业的稳定政治环境，爱尔兰现已成为全球制药生产的中心。此次该国两大领先的β-内酰胺类产品生产商的合并，为未来的增长和效率提升带来了重大机遇，将为两家公司、其利益相关者、合作伙伴和客户带来显著利益。

Both Gaelic Labs and Athlone are well established pharmaceutical manufacturers with strong reputations in Beta-Lactam antibiotics. Combining the two companies’ complementary offerings is expected to enable them both to strengthen their market presence, enhance product offerings, and drive operational efficiencies.

盖尔语实验室和阿斯隆都是知名的制药制造商，在β-内酰胺类抗生素领域享有盛誉。预计结合这两家公司的互补产品将能使它们加强市场地位、丰富产品供应并提升运营效率。

The acquisition also aligns with Gaelic Labs' long-term vision to establish itself as a leader in the pharmaceutical industry, particularly in the production and distribution of Beta Lactam generic medicines. .

此次收购也符合盖尔实验室的长期愿景，即确立其在制药行业的领导地位，特别是在β-内酰胺类仿制药的生产和分销方面。

“The deal is expected to deliver multiple financial and operational benefits, including cost savings through manufacturing consolidation, revenue growth and increased regulatory advantages,” says Brian Morrissey, General Manager of Gaelic Labs. “Athlone is a key player in the supply chain for Beta-Lactam antibiotics, so they are a great match for Gaelic Labs, and we will leverage many operational synergies.”.

“该交易预计将带来多项财务和运营优势，包括通过制造整合实现成本节约、收入增长以及监管优势增加，”Gaelic Labs总经理Brian Morrissey表示。“Athlone是β-内酰胺类抗生素供应链中的重要参与者，因此他们与Gaelic Labs非常匹配，我们将利用许多运营协同效应。”

Gaelic Labs is committed to retaining personnel at the Athlone Labs site, including the current management team, ensuring operational continuity and a seamless transition for partners, suppliers and customers.  Athlone’s C-suite will now report to Brian Morrisey, who will have hierarchical responsibility over both companies. .

盖尔语实验室致力于保留阿斯隆实验室基地的员工，包括现任管理团队，确保运营的连续性以及为合作伙伴、供应商和客户提供无缝过渡。阿斯隆的高层管理人员现在将向布赖恩·莫里斯报告，他将对两家公司负有层级责任。

“Gaelic Labs has always supported the creation of highly-skilled jobs in Ireland,” adds Brian. “With this acquisition, our total workforce has more than doubled to around 120 people, and we know that those people are the driving force behind our success. We are conducting several programs for smooth operational transitioning, and to ensure we retain the experience and expertise that Athlone has become known for.”.

“Gaelic Labs 一直支持在爱尔兰创造高技能工作岗位，”Brian 补充道。“通过这次收购，我们的总员工人数增加了一倍多，达到约 120 人，我们知道这些人是我们成功背后的驱动力。我们正在进行多项计划，以确保运营顺利过渡，并保留 Athlone 闻名的经验和专业知识。”

All existing product lines and customer contracts are expected to continue without disruption. Looking ahead, for customers of both companies, the acquisition is expected to bring advantages in terms of greater efficiencies, backed by investment from Gaelic Labs – which itself benefited from newly upgraded facilities two years ago – with a view to expanding both companies’ manufacturing capabilities and market presence, optimizing manufacturing processes, diversifying product portfolios, and aligning IT and compliance systems. .

所有现有产品线和客户合同预计将继续保持不间断。展望未来，对于两家公司的客户而言，此次收购预计将带来更高的效率优势，这得益于Gaelic Labs的投资——该公司本身两年前受益于新升级的设施——目的是扩大两家公司的制造能力和市场影响力，优化制造流程，丰富产品组合，并整合IT和合规系统。

For more information about Gaelic Laboratories and Athlone laboratories, visit their websites at https://gaeliclabs.com and https://www.athlone-laboratories.com, respectively.

有关盖尔实验室和阿斯隆实验室的更多信息，请分别访问其网站 https://gaeliclabs.com 和 https://www.athlone-laboratories.com。

Editor’s Note

编者注

For more information, please contact Tristan Jervis at Impact Shine Communications on +44 (0) 771 363 8396 or e-mail: t.jervis@impactshinecommunications.com.

如需更多信息，请联系Impact Shine Communications的特里斯坦·贾维斯，电话：+44 (0) 771 363 8396，或电子邮件：t.jervis@impactshinecommunications.com。

About Gaelic Laboratories

关于盖尔实验室

Gaelic Laboratories is a world-class manufacturer of Beta-Lactam (penicillin) products in tablet, capsule and powder for suspension form. Established in Ireland in 2022, and with newly upgraded facilities, we manufacture our own Beta-Lactam products (sold under the Gaelic Laboratories brand), as well as offering contract manufacturing and packaging services for markets across the EU, UK, the Middle East and North Africa.

盖尔实验室是世界一流的β-内酰胺（青霉素）产品制造商，产品包括片剂、胶囊和混悬粉。公司于2022年在爱尔兰成立，拥有全新升级的设施，我们生产自主品牌（盖尔实验室品牌）的β-内酰胺产品，同时为欧盟、英国、中东和北非市场的客户提供合同制造和包装服务。

Our site in Ireland is licenced by the HPRA. For more information about Gaelic Laboratories, please visit https://gaeliclabs.com. .

我们在爱尔兰的站点由爱尔兰卫生产品监管局（HPRA）许可。有关盖尔实验室的更多信息，请访问 https://gaeliclabs.com。

About Athlone Laboratories

关于阿斯隆实验室

Athlone Laboratories a leading developer and manufacturer of a broad range of oral dose beta-lactam products. Established in 1974, the company is an accredited supplier to local and many blue-chip customer partners across Europe, Asia-Pacific, Canada, Iraq and Brazil Our site in Ireland is licenced by the HPRA.

阿斯隆实验室是口服剂量β-内酰胺类产品的领先开发商和制造商，产品种类繁多。公司成立于1974年，是当地及欧洲、亚太地区、加拿大、伊拉克和巴西众多蓝筹客户合作伙伴的认证供应商。我们在爱尔兰的工厂获得了爱尔兰卫生产品监管局（HPRA）的许可。

For more information about Athlone Laboratories, please visit https://www.athlone-laboratories.com.

有关雅典实验室的更多信息，请访问 https://www.athlone-laboratories.com。